T1	intervention 58 67	Goserelin
T2	intervention 72 82	Raloxifene
T6	eligibility 497 538	Women at â‰¥30% lifetime risk breast cancer
T7	control 573 613	mammographic screening alone (C-Control)
T3	outcome-Measure 789 806	therapy adherence
T8	outcome-Measure 833 857	toxicity/quality of life
T9	outcome-Measure 859 881	change in bone density
T10	outcome-Measure 887 907	mammographic density
T11	total-participants 929 931	75
T12	iv-bin-abs 999 1001	20
T13	intervention-participants 1005 1007	38
T14	iv-bin-percent 1009 1012	52%
T15	outcome 1023 1059	completed the 2-year period of study
T16	cv-bin-abs 1085 1087	27
T17	control-participants 1088 1090	37
T18	cv-bin-percent 1092 1097	73.0%
T19	outcome 1100 1108	Dropouts
T20	outcome 1420 1445	Lumbar spine bone density
T4	outcome 1345 1373	toxicity and sexual problems
T5	outcome 1378 1395	change in anxiety
T21	outcome 1406 1418	cancer worry
